Equities
OTE Buys Back Nearly 300,000 Shares for €5.9 Million
Greek telecom operator OTE repurchased 299,531 shares between Sept. 7-11 at an average of €19.76, bringing its treasury holding to 3.46 million shares or 0.877% of outstanding stock.
ICU Medical Shifts Focus to Cash Returns Amid Growth Stability
CEO Vivek Jain outlines plans to reduce leverage by 2024 and prioritize shareholder returns, while maintaining mid-single-digit growth in core segments.
ALX Oncology Details Biomarker Strategy for CD47 Program at Cantor Conference
The biotech highlighted ASPEN-06 gastric data and an upcoming Phase II breast cancer study as it pushes a companion diagnostic with Ventana for its Evorpacept program.
Pennant International raises £400k short-term loan from shareholder
London-based AIM-listed Pennant International secures £600k unsecured loan to fund restructuring and bridge working capital needs ahead of Q4 2026 deliveries.
Pulsar Helium names David Young as CFO and director
Pulsar Helium has appointed David Young to serve as its chief financial officer and a director.
Mkango Resources Renamed Mkango Magnetic Materials
Mkango Resources announced a name change to Mkango Magnetic Materials.
ZenaTech Gains Irish Aviation Authorization for Aerial Crop Treatment Services
The Nasdaq-listed ag-tech firm received SORA approval from the Irish Aviation Authority to conduct drone-based fertilizer and bio-stimulant application on Irish farmland.
Enhertu receives EU committee backing for early breast cancer
Enhertu has been backed by an EU committee for use in early breast cancer, according to the announcement.
CXMT Shares Jump 2.6% After Fifth-Gen DRAM Platform Mass Production Announced
ChangXin Memory Technologies’ shares surged as the company’s new G5 DRAM platform entered production, marking a milestone in China’s push for self-sufficiency in advanced memory technology.
Sampo Repurchases 2.26 Million Shares in Week 38 at €9.41 Average
Sampo plc bought back 2.26 million A shares between Sept. 14-18 for an aggregate of roughly €21.3 million at its third weekly repurchase under the €350M program.
Sampo Buys Back 2.26 Million Shares in Third Week of Repurchase Program
The Finnish insurer repurchased 2.26 million A-shares at a weighted average of €9.41 during Sept 14–18 under its €350 million program.
SMI opens higher with Galderma, Sandoz debuts amid KI chip demand
Swiss equity markets expected to start the week on a positive note, with the SMI index poised for gains as pharmaceutical firms Galderma and Sandoz make their debut. Meanwhile, oil prices retreated despite escalating tensions in the Middle East.
Galderma, Sandoz enter SMI; Kühne+Nagel and Swisscom exit
SIX says Galderma and Sandoz will join the Swiss Blue Chips index Monday, replacing logistics firm Kühne+Nagel and telecom group Swisscom, which drop to the SMIM.
Speedy Hire Plc Approves Annual Meeting Resolutions with Strong Shareholder Support
London-based logistics firm Speedy Hire Plc secured unanimous approval for key resolutions at its annual general meeting, including dividend payouts and board changes.
Sun Hung Kai Reports 4.6% Profit Growth, Gearing Halved in FY2026
Hong Kong property developer Sun Hung Kai Properties Limited reported a 4.6% increase in profit attributable to shareholders and a significant reduction in gearing to 10.7% in FY2026, marking a 47% decline from its December 2023 peak.
Galderma CEO reaffirms growth outlook amid SMI ascent
Galderma’s Flemming Ørnskov highlights expansion in emerging markets and product innovation as key drivers of expected continued high growth.
Swiss Market Index faces seasonal volatility amid central-bank rate hikes
Analysts highlight dividend-paying stocks as a stable long-term wealth accumulation tool amid cautious optimism for Swiss equities.
SMI drops 0.47%, oil above $100 weighs on global equities
Swiss benchmark closed lower as crude prices surpassed $100 a barrel for the first time since May, while ECB raised rates as expected and US producer prices came in hotter than forecast.
SpyGlass Pharma’s Glaucoma Lens Nears Phase III Milestones with $920M Runway
The biotech firm’s BIM-IOL drug-delivery implant shows promising efficacy in reducing glaucoma medication use, with Wall Street targeting $37–$62 per share.
Mereo BioPharma shows pipeline progress at Cantor healthcare conference
CEO says three major regulatory and development milestones are weeks away for its alvelestat, setrusumab and vantictumab programs.
Arcturus Therapeutics Highlights Data Catalysts at Healthcare Conference
CEO Joseph Payne discusses Phase II readouts for OTC deficiency and cystic fibrosis programs, regulatory clarity, and platform advancements ahead of Q4 funding decisions.
Entergy Texas Declares $0.3359 Quarterly Dividend on Series A Preferred Stock
The utility’s board approved a quarterly cash dividend of $0.3359375 per share on its Series A preferred shares, payable Oct. 15 to shareholders of record on Oct. 2. Entergy Texas serves about 538,000 customers across 27 counties in Texas.
SBA Communications: 2026 growth stalls as 6G waits beyond 2028
Executive guidance highlights near-term financial pressures, including higher churn and interest costs, while long-term expansion hinges on 6G deployment.
Bernstein Maintains Outperform on Richemont, Keeps CHF 240 Target
Bernstein Research analyst Luca Solca reviewed Swiss watch export data and maintained Richemont remains his European luxury sector favorite, with the gradual demand recovery still intact.